COVID-19 impact on screening test volume through the National Breast and Cervical Cancer early detection program, January-June 2020, in the United States.

COVID-19 impact on screening test volume through the National Breast and Cervical Cancer early detection program, January-June 2020, in the United States.
复制标题

DOI:
10.1016/j.ypmed.2021.106559
复制
发表时间:
2021-10
影响因子:
5.1
通讯作者:
Richardson, L. C.
Richardson, L. C.
中科院分区:
医学2区
文献类型:
--
作者:
DeGroff, A.;Miller, J.;Sharma, K.;Sun, J.;Helsel, W.;Kammerer, W.;Rockwell, T.;Sheu, A.;Melillo, S.;Uhd, J.;Kenney, K.;Wong, F.;Saraiya, M.;Richardson, L. C.

文献摘要

参考文献

被引文献

相似文献

在美国,来自种族和少数民族群体的女性面临着不成比例的宫颈癌和乳腺癌负担。随着筛查服务的供需减少,2019年冠状病毒病(新冠肺炎)大流行可能会加剧这些差距。国家乳腺癌和宫颈癌早期检测计划(Nbccedp)为低收入和医疗保险不足的妇女提供癌症筛查服务。我们考察了新冠肺炎在2020年1-6月期间S对NBCCEDP筛查服务的影响。我们发现,在2020年4月期间,nbccedp资助的乳腺癌和宫颈癌筛查测试的总数与之前那个月的5年平均水平相比分别下降了87%和84%。下降的程度因地理、种族/民族和乡村而异。2020年4月,与之前5年的平均水平相比,卫生与公众服务区2-纽约的筛查测试量下降最严重(乳腺癌筛查为96%,宫颈癌筛查为95%)。降幅最大的是美国印第安人/阿拉斯加原住民妇女乳腺癌筛查(98%)和亚太岛民妇女宫颈癌筛查(92%)。检测量在5月开始回升,到2020年6月,nbccedp乳腺癌和宫颈癌筛查测试量分别比该月5年平均水平低39%和40%。然而,农村地区妇女的乳腺癌筛查仍比5年平均水平低50%以上。Nbccedp方案报告说,帮助卫生保健提供者恢复筛查。
Women from racial and ethnic minority groups face a disproportionate burden of cervical and breast cancers in the United States. The Coronavirus Disease 2019 (COVID-19) pandemic might exacerbate these disparities as supply and demand for screening services are reduced. The National Breast and Cervical Cancer Early Detection Program (NBCCEDP) provides cancer screening services to women with low income and inadequate health insurance. We examined COVID-19's impact on NBCCEDP screening services during January-June 2020. We found the total number of NBCCEDP-funded breast and cervical cancer screening tests declined by 87% and 84%, respectively, during April 2020 compared with the previous 5-year averages for that month. The extent of declines varied by geography, race/ethnicity, and rurality. In April 2020, screening test volume declined most severely in Health and Human Services Region 2 - New York (96% for breast, 95% for cervical cancer screening) compared to the previous 5-year averages. The greatest declines were among American Indian/Alaskan Native women for breast cancer screening (98%) and Asian Pacific Islander women for cervical cancer screening (92%). Test volume began to recover in May and, by June 2020, NBCCEDP breast and cervical cancer screening test volume was 39% and 40% below the 5-year average for that month, respectively. However, breast cancer screening remained over 50% below the 5-year average among women in rural areas. NBCCEDP programs reported assisting health care providers resume screening.
DOI: 10.15585/mmwr.ss6614a1
发表时间: 2017-07-07
影响因子: 24.9
作者:
Henley, S. Jane;Anderson, Robert N.;Richardson, Lisa C.
通讯作者: Richardson, Lisa C.
DOI: 10.1002/cncr.32207
发表时间: 2019-10-01
期刊: CANCER
影响因子: 6.2
作者:
Scott, Lia C.;Mobley, Lee R.;Il'yasova, Dora
通讯作者: Il'yasova, Dora
DOI: 10.5888/pcd18.200627
发表时间: 2021-01-07
影响因子: 5.5
作者:
Hacker KA;Briss PA
通讯作者: Briss PA
DOI: 10.1353/hpu.2011.0023
发表时间: 2011-02
影响因子: 1.4
作者:
Fiscella K;Humiston S;Hendren S;Winters P;Jean-Pierre P;Idris A;Ford P
通讯作者: Ford P
DOI: 10.15585/mmwr.mm7004a1externalicon
发表时间: 2021-01-29
影响因子: 33.9
作者:
Miller, Maureen J.;Xu, Lanfang;Chao, Chun R.
通讯作者: Chao, Chun R.